Adar1 Capital Management, LLC Astrazeneca PLC Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 700 shares of AZN stock, worth $46,564. This represents 0.01% of its overall portfolio holdings.
Number of Shares
700
Previous 100
600.0%
Holding current value
$46,564
Previous $7.8 Million
599.28%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.18 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.79 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.48 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.45 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...